Omega-3 polyunsaturated fatty acids (n-3 PUFAs) are promoted as cognitive enhancers with consumption recommended in the general population and those with neurocognitive deficits such as attention deficit hyperactivity disorder (ADHD). However, evidence from randomised placebo-controlled trials is inconclusive.
Aims:
This study aimed to conduct a systematic review and meta-analysis examining the effect of n-3 PUFA supplementation on cognition in healthy populations and those with ADHD and related disorders (RDs).
Methods:
Databases were searched for randomised controlled trials (RCTs) in adults and school-aged children (who were healthy and typically developing (TD) or had ADHD or a related-neurodevelopmental disorder (ADHD+RD) which assessed the effects of n-3 PUFA on cognition.
Results:
In the 24 included studies n-3 PUFA supplementation, in the whole sample and the TD and ADHD+RD subgroup, did not show improvements in any of the cognitive performance measures. In those with low n-3 PUFA status, supplementation improved short-term memory.
Conclusions:
There is marginal evidence that n-3 PUFA supplementation effects cognition in those who are n-3 PUFA deficient. However, there is no evidence of an effect in the general population or those with neurodevelopmental disorders. This has important implications given the widespread advertisement and consumption of n-3 PUFA; claims of cognitive benefit should be narrowed.
AbergMALAbergNBrismanJ. (2009) Fish intake of Swedish male adolescents is a predictor of cognitive performance. Acta Paediatr98: 555–560.
2.
AmmingerGPSchaferMRPapageorgiouK. (2010) Long-chain -3 fatty acids for indicated prevention of psychotic disorders. Arch General Psychiatry67: 146–154.
3.
AntypaNVan der DoesAJWSmeltAHM. (2009) Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers. J Psychopharmacol23: 831–840.
4.
AssisiABanziRBuonocoreC. (2006) Fish oil and mental health: The role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders. Int Clin Psychopharmacol21: 319–336.
5.
BanaschewskiTCoghillDSantoshP. (2006) Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry15: 476–495.
6.
BaumgartnerJSmutsCMMalanL. (2012) Effects of iron and n-3 fatty acid supplementation, alone and in combination, on cognition in school children: A randomized, double-blind, placebo-controlled intervention in South Africa. Am J Clin Nutr96: 1327–1338.
7.
BédardA-CVSteinMAHalperinJM. (2015) Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder. J Child Psychol Psychiatry56: 40–48.
8.
BentonDDonohoeRTClaytonDE. (2013) Supplementation with DHA and the psychological functioning of young adults. Br J Nutr109: 155–161.
9.
BlochMHQawasmiA (2011) Omega-3 Fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: Systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry50: 991–1000,
10.
BryanJPhDOsendarpS. (2004) Nutrients for cognitive development in school-aged children. Nutr Rev62: 295–306.
11.
CoghillDRRhodesSMMatthewsK (2007) The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder. Biol Psychiatry62: 954–962.
12.
CoghillDRSethSPedrosoS. (2014) Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder: Evidence from a systematic review and a meta-analysis. Biol PsychiatryElsevier, 76: 603–615.
13.
CohenJ (1988) Statistical Power Analysis for the Behavioural Sciences. 2nd ed.Hillsdale New Jersey: Erlbaum.
14.
DaltonAWolmaransPWitthuhnRC. (2009) A randomised control trial in schoolchildren showed improvement in cognitive function after consuming a bread spread, containing fish flour from a marine source. Prostaglandins Leukot Essent Fatty Acid80: 143–149.
FaraoneS VBuitelaarJ (2010) Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eurn Child Adolesc Psychiatry19: 353–364.
19.
FieldAPGillettR (2010) How to do a meta-analysis. Br J Math Stat Psychol63: 665–694.
20.
FrazierTWDemareeHAYoungstromEA (2004) Meta-analysis of intellectual and neuropsychological test performance in attention-deficit/hyperactivity disorder. Neuropsychology18: 543–555.
21.
GoyensPLLSpilkerMEZockPL. (2005) Compartmental modeling to quantify alpha-linolenic acid conversion after longer term intake of multiple tracer boluses. J Lipid Res46: 1474–1483.
22.
GreenbergLMKindschiCL (1996) T.O.V.A. Test of Variables of Attention: Clinical Guide. Los Alamitos, California: Universal Attention Disorders Inc.
23.
GustafssonPBirberg-ThornbergUDuchénK. (2010) EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD. Acta Paediatr99: 1540–1549.
24.
HamazakiTSawazakiSItomuraM. (1996) Rapid publication the effect of docosahexaenoic acid on aggression in young adults. J Clin Invest97: 1129–1133.
25.
HibbelnJRDavisJMSteerC. (2007) Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): An observational cohort study. Lancet,369: 578–585.
26.
HigginsJPTGreenS (eds) (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available at www.cochrane-handbook.org
27.
HirayamaSHamazakiTTerasawaK (2004) Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder – a placebo-controlled double-blind study. Eur J Clin Nutr58: 467–473.
28.
HorrocksL aYeoYK (1999) Health benefits of docosahexaenoic acid (DHA). Pharmacoll Res40: 211–225.
29.
JacksonPDearyMEReayJL. (2012) No effect of 12 weeks’ supplementation with 1 g DHA-rich or EPA-rich fish oil on cognitive function or mood in healthy young adults aged 18-35 years. Br J Nutr107: 1232–1243.
30.
KairaluomaLNärhiVAhonenT. (2009) Do fatty acids help in overcoming reading difficulties? A double-blind, placebo-controlled study of the effects of eicosapentaenoic acid and carnosine supplementation on children with dyslexia. Child Care Health Dev35: 112–119.
31.
KalmijnSvan BoxtelMPJOckéM. (2004) Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology62: 275–280.
32.
KarrJEGrindstaffTRAlexanderJE (2012) Omega-3 polyunsaturated fatty acids and cognition in a college-aged population. Exp Clin Psychopharmacol20: 236–242.
33.
KennedyDOJacksonP aElliottJM. (2009) Cognitive and mood effects of 8 weeks’ supplementation with 400 mg or 1000 mg of the omega-3 essential fatty acid docosahexaenoic acid (DHA) in healthy children aged 10-12 years. Nutr Neurosci12: 48–56.
34.
KirbyAWoodwardAJacksonS. (2010) A double-blind, placebo-controlled study investigating the effects of omega-3 supplementation in children aged 8-10 years from a mainstream school population. Res Dev Disabil31: 718–730.
35.
KuntsiJWoodACVan Der MeereJ. (2009) Why cognitive performance in ADHD may not reveal true potential: Findings from a large population-based sample. J Int Neuropsychol Soc JINS15: 570–579.
36.
LeonardBEMcCartanDWhiteJ. (2004) Methylphenidate: A review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol19: 151–180.
37.
LongSBentonD (2013) A double-blind trial of the effect of docosahexaenoic acid and vitamin and mineral supplementation on aggression, impulsivity, and stress. Hum Psychopharmacol28: 238–247.
38.
MazereeuwGLanctôtKLChauS a. (2012) Effects of ω-3 fatty acids on cognitive performance: A meta-analysis. Neurobiol Aging33: 1482.e17–29.
39.
McNamaraRKAbleJJandacekR. (2010) Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: A placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Am J Clin Nutr91: 1060–1067.
40.
MilteCMParlettaNBuckleyJD. (2012) Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: A randomized controlled trial. Nutrition28: 670–677.
41.
MoherDLiberatiATetzlaffJ. (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS medicine, 6: e1000097.
42.
MorrisSB (2007) Estimating effect sizes from pretest-posttest-control group designs. Organizational Research Methods, 11: 364–386.
43.
NasrallahH ALoneyJOlsonSC. (1986) Cortical atrophy in young adults with a history of hyperactivity in childhood. Psychiatry Res17: 241–246.
44.
NiggJTWillcuttEGDoyleAE. (2005) Causal heterogeneity in attention-deficit/hyperactivity disorder: Do we need neuropsychologically impaired subtypes?Biol Psychiatry57: 1224–1230.
45.
OrtegoCBotellaJ (2010) The hard but necessary task of gathering order-one effect size indices in meta-analysis. Psicológica31: 291–315.
46.
OsendarpSJMBaghurstKIBryanJ. (2007) Effect of a 12-mo micronutrient intervention on learning and memory in well-nourished and marginally nourished school-aged children: 2 Parallel, randomized, placebo-controlled studies in Australia and Indonesia. Am J Clin Nutr86: 1082–1093.
47.
ParlettaNCooperPGentDN. (2013) Effects of fish oil supplementation on learning and behaviour of children from Australian Indigenous remote community schools: A randomised controlled trial. Prostaglandins Leukot Essent Fatty Acid89: 71–79.
48.
PeetMHorrobinDF (2002) A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry59: 913–919.
49.
Portillo-ReyesVPérez-GarcíaMLoya-MéndezY. (2014) Clinical significance of neuropsychological improvement after supplementation with omega-3 in 8-12 years old malnourished Mexican children: A randomized, double-blind, placebo and treatment clinical trial. Res Dev Disabil35: 861–870.
50.
RichardsonAJ (2006) Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. Int Rev Psychiatry18: 155–172.
51.
RichardsonAJMontgomeryP (2005) The Oxford-Durham study: A randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics115: 1360–1366.
52.
RichardsonAJBurtonJRSewellRP. (2012) Docosahexaenoic acid for reading, cognition and behavior in children aged 7-9 years: A randomized, controlled trial (the DOLAB Study). PloS One7: e43909.
53.
RyanASNelsonEB (2008) Assessing the effect of docosahexaenoic acid on cognitive functions in healthy, preschool children: A randomized, placebo-controlled, double-blind study. Clin Pediatr (Phila)47: 355–362.
54.
SchulzKPFanJBeA V (2014) Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry69: 952–961.
55.
SimmerKPatoleSKRaoSC (2011) Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev12: 1–72.
56.
SinnNBryanJWilsonC (2008) Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: A randomised controlled trial. Prostaglandins Leukot Essent Fatty Acid78: 311–326.
57.
Sonuga-BarkeEBitsakouPThompsonM (2010) Beyond the dual pathway model: Evidence for the dissociation of timing, inhibitory, and delay-related impairments in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry49: 345–355.
58.
Sonuga-BarkeEJSBrandeisDCorteseS. (2013) Nonpharmacological interventions for ADHD: Systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry170: 275–289.
59.
StataCorp (2009) Stata Statistical Software: Release 11. College Station, Texas: StataCorp LP.
60.
StevensLZhangWPeckL. (2003) EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids38: 1007–1021.
61.
StonehouseWConlonCAPoddJ. (2013) DHA supplementation improved both memory and reaction time in healthy young adults: A randomized controlled trial. Am J Clin Nutr97: 1134–1143.
62.
SuK-PLaiH-CYangH-T. (2014) Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: Results from a randomized, controlled trial. Biol Psychiatry76: 559–566.
63.
VaismanNKaysarNZaruk-adashaY. (2008) Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention. Am J Clin Nutr87: 1170–1180.
64.
VoigtRGLlorenteAMJensenCL. (2001) A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. Journal of Pediatrics139: 189–196.
65.
WechslerD (1991) Manual for the Wechsler Scale of Children’s Intelligence-III. New York: Psychological Corporation.
66.
Widenhorn-MüllerKSchwandaSScholzE. (2014) Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): A randomized placebo-controlled intervention trial. Prostaglandins Leukot Essent Fatty Acids91: 49–60.
67.
WillcuttEGPenningtonBFDuncanL. (2010) Understanding the complex etiologies of developmental disorders: Behavioral and molecular genetic approaches. J Dev Behav Pediatr31: 533–544.
YuiKKoshibaMNakamuraS. (2012) Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: A double-blind, placebo-controlled, randomized trial. J Clin Psychopharmacol32: 200–206.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
